Ocular Therapeutix, Inc. focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases.
Market Cap | 395.063 Million | Shares Outstanding | 77.01 Million | Avg 30-day Volume | 1.124 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.31 |
Price to Revenue | 13.1582 | Debt to Equity | 0.5845 | EBITDA | 7.134 Million |
Price to Book Value | 6.5077 | Operating Margin | -179.3047 | Enterprise Value | 459.941 Million |
Current Ratio | 7.264 | EPS Growth | 0.617 | Quick Ratio | 7.036 |
1 Yr BETA | 1.6034 | 52-week High/Low | 6.53 / 2.57 | Profit Margin | -15.0568 |
Operating Cash Flow Growth | -22.3998 | Altman Z-Score | 0.39 | Free Cash Flow to Firm | -132.325 Million |
Earnings Report | 2023-05-10 |
Please sign in first
none
44.6 Thousand total shares from 5 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
WHITE CHRISTOPHER G CHIEF BUSINESS OFFICER |
|
94,766 | 2023-02-06 | 3 |
MATTESSICH ANTONY C. PRESIDENT AND CEO |
|
446,281 | 2023-02-06 | 2 |
NOTMAN DONALD CHIEF FINANCIAL OFFICER |
|
139,387 | 2023-02-06 | 2 |
OZDEN RABIA GURSES CHIEF MEDICAL OFFICER |
|
101,363 | 2023-02-06 | 4 |
STRASSBURGER PHILIP C. GENERAL COUNSEL |
|
109,071 | 2023-02-06 | 2 |
|
6,122,089 | 2022-11-07 | 3 | |
|
16,000 | 2022-10-17 | 3 | |
|
35,733 | 2022-06-16 | 1 | |
|
135,202 | 2022-06-16 | 2 | |
|
75,264 | 2022-06-16 | 1 | |
|
40,233 | 2022-06-16 | 1 | |
|
35,733 | 2022-06-16 | 1 | |
GOLDSTEIN MICHAEL H. PRESIDENT, OPHTHALMOLOGY & CMO |
|
503,335 | 2022-02-03 | 0 |
|
18,000 | 2021-06-18 | 0 | |
KITCHEN PATRICIA CHIEF OPERATING OFFICER |
|
0 | 2021-02-17 | 0 |
|
No longer subject to file | 2020-04-03 | 0 | |
SAWHNEY AMARPREET CHAIRMAN OF THE BOARD |
|
3,014,973 | 2019-06-06 | 0 |
BOLLAG DANIEL M SR. VP REG. AFFAIRS & QUALITY |
|
0 | 2019-01-02 | 0 |
HANLEY KEVIN F. SR. VP TECHNICAL OPERATIONS |
|
0 | 2019-01-02 | 0 |
|
0 | 2018-06-14 | 0 | |
|
0 | 2018-06-14 | 0 | |
|
0 | 2017-06-01 | 0 | |
MIGAUSKY GEORGE V INTERIM CFO |
|
0 | 2017-04-06 | 0 |
SMITH W BRADFORD CFO AND TREASURER |
|
0 | 2017-01-31 | 0 |
FORTUNE JAMES CHIEF OPERATING OFFICER |
|
0 | 2017-01-31 | 0 |
ANKERUD ERIC SEE REMARKS |
|
0 | 2017-01-31 | 0 |
TALAMO JONATHAN H. CHIEF MEDICAL OFFICER |
|
0 | 2017-01-31 | 0 |
HURLEY CHARLES ANDREW CHIEF COMMERCIAL OFFICER |
|
0 | 2017-01-31 | 0 |
|
No longer subject to file | 2015-06-15 | 0 | |
SV LIFE SCIENCES FUND IV (GP), L.P. |
|
No longer subject to file | 2015-06-10 | 0 |
POLARIS VENTURE MANAGEMENT CO. V, L.L.C. POLARIS VENTURE PARTNERS V, L.P. POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P. |
|
No longer subject to file | 2015-02-02 | 0 |
|
4,046,430 | 2014-07-30 | 0 | |
|
0 | 2014-07-24 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-02-08 19:29:42 -0500 | 2023-02-06 | S | 19,669 | $4.24 | d | 446,281 | direct | yes | -1.7766 | 46.9543 | 54.5685 | 5 | -1.7766 | 2 | ||
2023-02-08 19:31:48 -0500 | 2023-02-06 | S | 6,181 | $4.24 | d | 109,071 | direct | yes | -1.7766 | 46.9543 | 54.5685 | 5 | -1.7766 | 2 | ||
2023-02-08 19:33:40 -0500 | 2023-02-06 | S | 6,416 | $4.24 | d | 101,363 | direct | yes | -1.7766 | 46.9543 | 54.5685 | 5 | -1.7766 | 2 | ||
2023-02-08 19:32:37 -0500 | 2023-02-06 | S | 6,476 | $4.24 | d | 139,387 | direct | yes | -1.7766 | 46.9543 | 54.5685 | 5 | -1.7766 | 2 | ||
2023-02-08 19:38:30 -0500 | 2023-02-06 | S | 5,829 | $4.24 | d | 94,766 | direct | yes | -1.7766 | 46.9543 | 54.5685 | 5 | -1.7766 | 2 | ||
2023-02-01 19:32:25 -0500 | 2023-01-30 | A | 176,300 | a | 465,950 | direct | 1.8868 | -7.0755 | 16.9811 | 47.8774 | 12 | -8.7264 | 7 | |||
2023-02-01 19:32:25 -0500 | 2023-01-30 | A | 536,900 | a | 536,900 | direct | ||||||||||
2023-02-01 19:33:27 -0500 | 2023-01-30 | A | 55,556 | a | 145,863 | direct | 1.8868 | -7.0755 | 16.9811 | 47.8774 | 12 | -8.7264 | 7 | |||
2023-02-01 19:33:27 -0500 | 2023-01-30 | A | 166,667 | a | 166,667 | direct | ||||||||||
2023-02-01 19:34:30 -0500 | 2023-01-30 | A | 50,000 | a | 50,000 | direct | ||||||||||
2023-02-01 19:34:30 -0500 | 2023-01-30 | A | 55,556 | a | 107,779 | direct | 1.8868 | -7.0755 | 16.9811 | 47.8774 | 12 | -8.7264 | 7 | |||
2023-02-01 19:34:30 -0500 | 2023-01-30 | A | 166,667 | a | 166,667 | direct | ||||||||||
2023-02-01 19:36:49 -0500 | 2023-01-30 | A | 44,444 | a | 100,595 | direct | 1.8868 | -7.0755 | 16.9811 | 47.8774 | 12 | -8.7264 | 7 | |||
2023-02-01 19:36:49 -0500 | 2023-01-30 | A | 133,333 | a | 133,333 | direct | ||||||||||
2023-02-01 19:35:40 -0500 | 2023-01-30 | A | 55,556 | a | 115,252 | direct | 1.8868 | -7.0755 | 16.9811 | 47.8774 | 12 | -8.7264 | 7 | |||
2023-02-01 19:35:40 -0500 | 2023-01-30 | A | 166,667 | a | 166,667 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 20:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 20:15:04 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 19:45:04 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 19:15:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 18:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 18:15:05 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 17:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 17:15:04 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 16:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 16:15:04 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 15:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 15:15:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 14:45:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 14:15:03 UTC | 2.6487 | 1.9213 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 13:45:04 UTC | 2.4407 | 2.1293 | 4000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 13:15:03 UTC | 2.4407 | 2.1293 | 4100000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-22 12:45:03 UTC | 2.4407 | 2.1293 | 4100000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-21 22:15:04 UTC | 2.4407 | 2.1293 | 3000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-21 21:45:03 UTC | 2.4407 | 2.1293 | 3000000 |
OCULAR THERAPEUTIX INC OCUL | 2023-03-21 21:15:03 UTC | 2.4407 | 2.1293 | 3000000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|